Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Insulin Resistance & Diabetes

Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes

O. O. Ojo; D. K. Srinivasan; B. O. Owolabi; P. R. Flatt; Y. H. A. Abdel-Wahab Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes Biochimie
Appetite & Satiety Insulin Resistance & Diabetes

Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation

A. M. Murphy; A. Thomas; S. J. Crinion; B. D. Kent; M. M. Tambuwala; A. Fabre; J. L. Pepin; H. M. Roche; C. Arnaud; S. Ryan Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Eur Respir J
Insulin Resistance & Diabetes

Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses

A. O'Brien; R. M. Loftus; M. M. Pisarska; L. M. Tobin; R. Bergin; N. A. W. Wood; C. Foley; A. Mat; F. C. Tinley; C. Bannan; G. Sommerville; N. Veerapen; G. S. Besra; L. V. Sinclair; P. N. Moynagh; L. Lynch; D. K. Finlay; D. O'Shea; A. E. Hogan Obesity Reduces mTORC1 Activity in Mucosal-Associated Invariant T Cells, Driving Defective Metabolic and Functional Responses J Immunol
Insulin Resistance & Diabetes

Emerging therapeutic potential for peptide YY for obesity-diabetes

R. A. Lafferty; P. R. Flatt; N. Irwin Emerging therapeutic potential for peptide YY for obesity-diabetes Peptides
Insulin Resistance & Diabetes

Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes

R. A. Lafferty; P. R. Flatt; N. Irwin Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes Curr Opin Endocrinol Diabetes Obes
Insulin Resistance & Diabetes

Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice

N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol
Insulin Resistance & Diabetes

Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes

N. Irwin; I. A. Montgomery; F. P. O'Harte; P. Frizelle; P. R. Flatt Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes Int J Obes (Lond)
Insulin Resistance & Diabetes

Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes

N. Irwin; V. A. Gault; F. P. M. O'Harte; P. R. Flatt Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes Peptides
Insulin Resistance & Diabetes

New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders

N. Irwin; P. R. Flatt New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders World J Diabetes
Insulin Resistance & Diabetes

Emerging therapeutic potential for xenin and related peptides in obesity and diabetes

S. L. Craig; V. A. Gault; N. Irwin Emerging therapeutic potential for xenin and related peptides in obesity and diabetes Diabetes Metab Res Rev
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page8 Page9 Page10 … Page34 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI